Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its class since 1968. “Gram-negative bacteria” pose a huge threat to ...

One of the primary mechanisms of antibiotic resistance in gram-negative bacteria is the use of efflux pumps. These protein pumps are designed to remove hazardous compounds (such as antibiotics ...

Gram-negative bacteria develop resistance to commonly prescribed antibiotics through ... Antibiotic treatment guidelines consistently recommended empiric therapy upon patient presentation ...

But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter ...

Gram-positive and gram-negative bacteria are distinct types of bacteria. Learn more here. ... It also outlines their differences, the infections they cause, and discusses antibiotic resistance.

"There is some evidence that antibiotic resistance reveals itself in other ways; for example, the morphology of Gram-negative ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

First, gram-negative bacteria have a thin cell wall that is about 1.5 to 10 nanometers across, ... —Bacteria that switch antibiotic resistance on and off are going undetected.

Gram-negative bacteria have the ability to cause a lot of diseases in humans. They can reach almost all of the organ systems. Your doctor may need to try several antibiotics to beat the infection.